Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365508 · ClinicalTrials.gov registry record · Phase 4
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
A Phase 4 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 642
- Enrollment target
NCT00365508: Completed Phase 4 study, sponsored by Fox Chase Cancer Center.
NCT00365508 is a Phase 4 study that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 642 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (24% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00365508, a Phase 4 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 642 participants
- Enrollment target
Study Summary
RATIONALE: Stop-smoking plans, including counseling and nicotine replacement therapy, may help smokers quit smoking. It is not yet known whether counseling and the nicotine lozenge is more effective than counseling and the nicotine patch in helping adult smokers quit smoking. PURPOSE: This randomized phase III trial is studying counseling and the nicotine lozenge to see how well they work compared to counseling and the nicotine patch in helping smokers quit smoking.
Interventions
- DRUG nicotine patch
- DRUG nicotine lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 642 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
What the finished NCT00365508 record still lists
NCT00365508 is an interventional study that assigns participants to a tested intervention. The registered 642 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (24% higher).
The record links to 0 conditions, and to 2 interventions - of which nicotine patch is the first listed.
NCT00365508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00365508 about?
NCT00365508 is a clinical study titled "Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking". RATIONALE: Stop-smoking plans, including counseling and nicotine replacement therapy, may help smokers quit smoking. It is not yet known whether counseling and the nicotine lozenge is more effective than counseling and the nicotine patch in helping adult smokers quit smoking. PURPOSE: This randomiz...
What is the current status of trial NCT00365508?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 642 participants. The study started on 2006-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00365508?
The interventions under investigation include: nicotine patch (DRUG), nicotine lozenge (DRUG).
Who is sponsoring clinical trial NCT00365508?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00365508's enrollment target sits among peer trials
642 126th of 2000 higher than 1,875 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- NCT06319820 · 641 participants · Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- NCT06625060 · 641 participants · Phase 2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia